Literature DB >> 30007985

A Comprehensive Diagnostic Algorithm for Direct Antiglobulin Test-Negative Autoimmune Hemolytic Anemia Reveals the Relative Ratio of Three Mechanisms in a Single Laboratory.

Toyomi Kamesaki, Eiji Kajii.   

Abstract

BACKGROUND: Direct antiglobulin test (DAT)-negative warm autoimmune hemolytic anemia (AIHA) is mainly caused by three mechanisms: red blood cell (RBC)-bound immunoglobulin (Ig)G below the detection limit of routine DAT; RBC-bound IgA or IgM; or low-affinity autoantibodies. Although most cases of DAT-negative AIHA are thought to be caused by RBC-bound IgG, and combinatory serological analyses are recommended, the relative ratios of each mechanism have not been clarified.
METHODS: Two groups of patients with undiagnosed hemolytic anemia and negative conventional tube method-DAT (TM-DAT) were investigated using anti-IgA and anti-IgM sera, or column agglutination method-DAT (CM-DAT), respectively, in addition to radioimmunological quantitation of RBC-bound IgG.
RESULTS: Three of 73 patients with DAT-negative AIHA showed positive RBC-bound IgA and normal amounts of RBC-bound IgG. Another group of 3 patients were RBC-bound IgM-positive, but only one of these showed normal amounts of RBC-bound IgG. In another group of patients with DAT-negative AIHA, 4 of the 20 showed positive CM-DAT and negative CM-DAT after washing RBCs. Three of these patients had normal amounts of RBC-bound IgG. Five patients with positive CM-DAT both before and after washing RBCs had high amounts of RBC-bound IgG.
CONCLUSION: Relative ratios of patients with DAT-negative AIHA resulting from RBC-bound IgG, RBC-bound IgA, RBC-bound IgM, and low-affinity IgG were estimated as 80, 4, 1 and 15%, respectively. A new classification and diagnostic algorithm for DAT-negative AIHA were proposed.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Autoimmune hemolytic anemia; Diagnostic algorithm; Direct antiglobulin test; IgA/M; Low-affinity IgG

Mesh:

Substances:

Year:  2018        PMID: 30007985     DOI: 10.1159/000488753

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  6 in total

Review 1.  Development of New Drugs for Autoimmune Hemolytic Anemia.

Authors:  Zhengrui Xiao; Irina Murakhovskaya
Journal:  Pharmaceutics       Date:  2022-05-11       Impact factor: 6.525

2.  Effect of dilution of canine blood samples on the specificity of saline agglutination tests for immune-mediated hemolysis.

Authors:  Prudence L Sun; Unity Jeffery
Journal:  J Vet Intern Med       Date:  2020-11-10       Impact factor: 3.333

Review 3.  Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia.

Authors:  Irina Murakhovskaya
Journal:  J Clin Med       Date:  2020-12-13       Impact factor: 4.241

4.  A Case of Coombs-Negative Hemolytic Anemia Prompting Diagnosis of SARS-CoV-2.

Authors:  Thanuja Neerukonda; Walid Moughabel; Justin Chen; Devansh Patel; Faiza Manji
Journal:  Cureus       Date:  2021-11-30

5.  Severe hemolysis with negative direct antiglobulin test: A case report.

Authors:  Mahin Behzadifard; Ali Arianezhad; Ali Bandehzadeh; Mohammadali Gholampour
Journal:  Ann Med Surg (Lond)       Date:  2022-08-18

6.  Coombs-negative hemolytic anemia in a male with COVID-19.

Authors:  Ju Young Bae; June Evelyn Jeon; Khalil Ian Hussein; Merlin Sung Lee
Journal:  Clin Case Rep       Date:  2021-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.